Nonalcoholic fatty liver disease and the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: the hidden danger.
Wisam SbeitTawfik KhouryDov WengrowerDan M LivovskyBashar FteihaAdi NubaniEran GoldinMahmud MahamidPublished in: Scandinavian journal of gastroenterology (2021)
NAFLD was shown to be a risk factor for PEP. Therefore, we suggest considering prophylactic pancreatic stenting and/or NSAID's suppositories among these patients.